Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Corral, US

Celestino Corral, Ocala, FL US

Patent application numberDescriptionPublished
20090144028METHOD AND APPARATUS OF COMBINING MIXED RESOLUTION DATABASES AND MIXED RADIO FREQUENCY PROPAGATION TECHNIQUES06-04-2009
20090144037METHOD AND APPARATUS FOR ENHANCING THE ACCURACY AND SPEED OF A RAY LAUNCHING SIMULATION TOOL06-04-2009
20090144311METHOD AND APPARATUS FOR DEVELOPING HIGH RESOLUTION DATABASES FROM LOW RESOLUTION DATABASES06-04-2009
20090167756METHOD AND APPARATUS FOR COMPUTATION OF WIRELESS SIGNAL DIFFRACTION IN A THREE-DIMENSIONAL SPACE07-02-2009

Celestino A. Corral, Ocala, FL US

Patent application numberDescriptionPublished
20090140949SYSTEM AND METHOD TO IMPROVE RF SIMULATIONS06-04-2009
20120033619DYNAMIC BIT ALLOCATION FOR COMMUNICATION NETWORKS SUBJECT TO BURST INTERFERENCE - Wired and wireless communication networks can be subject to burst interference resulting in loss of throughput and data corruption. In a communication system comprising a transmitting network device and a receiving network device, the transmitting network device can be configured to implement a dynamic bit allocation technique for retransmitting packets of a failed packet transmission. On receiving a request for retransmission from the receiving network device, the transmitting network device can dynamically allocate bits of original symbols across two or more constituent symbols per original symbol. The transmitting network device can allocate the two or more constituent symbols across one or more retransmission packets to exploit time diversity. The transmitting network device can also vary modulation and coding schemes and other transmit parameters to generate robust retransmission packets.02-09-2012
20120033682BALANCED BIT LOADING FOR COMMUNICATION NETWORKS SUBJECT TO BURST INTERFERENCE - Wired and wireless communication networks can be subject to burst interference resulting in loss of throughput and data corruption. In a communication system comprising a transmitting network device and a receiving network device, the transmitting network device can be configured to implement balanced bit loading for retransmitting packets of a failed packet transmission. On receiving a request for retransmission from the receiving network device, the transmitting network device can identify and eliminate sub-carriers that are associated with a bit load that is less than a predefined bit load threshold. The transmitting network device can attempt to reallocate bit loads of the eliminated sub-carriers to remaining sub-carriers across two or more constituent symbols per original symbol.02-09-2012

Chris Corral, Paso Robles, CA US

Patent application numberDescriptionPublished
20120055572Backflow Prevention and Method of Manufacture - A backflow prevention assembly is disclosed including a backflow prevention valve having a valve housing including a valve inlet end and a valve outlet end; a spool spacer of predetermined length having a first end and a second end; an inlet shut-off valve; and an outlet shut-off valve, wherein the spool spacer extends between the backflow prevention valve and one of the inlet shut-off valve and the outlet shut-off valve. The entire assembly, including the backflow prevention valve, the spool spacer, the inlet shut-off valve, and the outlet shut-off valve, is a certified assembly, certified by a certifying authority prior to installation. Methods of manufacturing a backflow prevention assembly and replacing a backflow prevention assembly are also disclosed.03-08-2012

Claudia Ivonne Corral, Savage, MN US

Patent application numberDescriptionPublished
20090046985Fiber Optic Enclosure Internal Cable Management - A fiber access terminal assembly includes a front housing piece with an exterior side and an interior side having a slack storage area and a rear housing piece mounted to the interior side of the front housing piece. A bend radius limiter having a retention portion with a first end and an oppositely disposed second end, a radius limiting portion disposed at the first end, and a side portion disposed at the second end is mounted in the slack storage area. The retention portion, the radius limiting portion, and the side portion cooperatively define a passageway for optical fiber routing. A method of routing cable in the fiber access terminal includes providing a fiber access terminal assembly, inserting cable through a cable entry in the housing, routing optical fibers of the cable loosely through the passageway, and connecting ends of the optical fiber to fiber optic adapters.02-19-2009

Danny Corral, Dekalb, IL US

Patent application numberDescriptionPublished
20120090269Blister Packaging Container Sealing Tool and Method - A container comprises a plastic blister with a first planar peripheral edge and a formed, first open-sided volume extending from the plane of the peripheral edge joined with a paperboard tray with a second planar peripheral edge, the paperboard tray having a plurality of panels connected at fold lines and forming a second open-sided volume. The container has means for joining the first planar peripheral edge of the plastic blister and the second planar peripheral edge of the paperboard tray so that the first and second volumes form a combined container volume. The paperboard tray may be a wedge-shaped tray, with greater depth at one end than at the other end. The container may be filled and sealed on conventional equipment used for blister packages with minor changes in tooling04-19-2012

Jose De Corral, Grafton, MA US

Patent application numberDescriptionPublished
20080206067High Pressure Pump Control - A feedback control loop for a high pressure pump modifies the accumulator velocity and pressure during solvent transfer. The accumulator velocity is adjusted to maintain the system pressure equal to the expected pressure to thereby eliminate the effect of the flow deficit created by a thermal effect.08-28-2008
20090294344Fluid mixer assembly - Disclosed is an assembly for mixing fluids (i.e., gases or liquids), and more particularly an assembly that accurately mixes two or more high-pressure fluid sources and is adapted for use in applications, such as for example, chromatography. The mixer assembly includes, inter alia, a housing, an inlet fitting, and a mixer cartridge assembly. The housing has a fluid receiving section and a fluid discharge section with a fluid outlet formed therein. A central bore extends between the fluid receiving section and fluid discharge section. An inlet fitting is engaged with the housing and has first and second fluid inlet ports formed therein that extend from the fitting exterior to the fluid receiving section of the housing. A mixer cartridge assembly is disposed within the central bore of the housing and is positioned between the inlet fitting and the downstream end portion of the housing. The mixer cartridge assembly includes a body portion, a plurality of spheres disposed within a central mixing chamber formed in the body portion, and mechanism for retaining the spheres in the mixing chamber.12-03-2009
20100189574HIGH PRESSURE PUMP CONTROL - A feedback control loop for a high pressure pump modifies the accumulator velocity and pressure during solvent transfer. The accumulator velocity is adjusted to maintain the system pressure equal to the expected pressure to thereby eliminate the effect of the flow deficit created by a thermal effect.07-29-2010
20100202897HIGH PRESSURE PUMP CONTROL - A feedback control loop for a high pressure pump modifies the accumulator velocity and pressure during solvent transfer. The accumulator velocity is adjusted to maintain the system pressure equal to the expected pressure to thereby eliminate the effect of the flow deficit created by a thermal effect.08-12-2010

Patent applications by Jose De Corral, Grafton, MA US

Laura Corral, Belmont, MA US

Patent application numberDescriptionPublished
20090220424Pro104 Antibody Compositions and Methods of Use - The invention provides isolated anti-ovarian, pancreatic, lung or breast cancer antigen (Pro104) antibodies that bind to Pro104 on a mammalian cell in vivo. The invention also encompasses compositions comprising an anti-Pro104 antibody and a carrier. These compositions can be provided in an article of manufacture or a kit. Another aspect of the invention is an isolated nucleic acid encoding an anti-Pro104 antibody, as well as an expression vector comprising the isolated nucleic acid. Also provided are cells that produce the anti-Pro104 antibodies. The invention encompasses a method of producing the anti-Pro104 antibodies. Other aspects of the invention are a method of killing a Pro104-expressing cancer cell, comprising contacting the cancer cell with an anti-Pro104 antibody and a method of alleviating or treating a Pro104-expressing cancer in a mammal, comprising administering a therapeutically effective amount of the anti-Pro104 antibody to the mammal.09-03-2009

Laura Corral, San Francisco, CA US

Patent application numberDescriptionPublished
20090232732PRO108 Antibody Compositions and Methods of Use and Use of PRO108 to Assess Cancer Risk - This invention relates to a method for assessing risk of prostate cancer. Specifically, it relates to utilizing both Pro108 and Prostate Specific Antigen (PSA) in combination to determine the risk of prostate cancer. In addition, it is directed to a method for assessing risk of ovarian, colon, breast or stomach cancer utilizing Pro108 or specific antibodies to Pro108. The invention provides isolated anti-prostate, ovarian, colon, breast or stomach cancer antigen (Pro108) antibodies that bind to Pro108 on a mammalian cell in vivo. The invention also encompasses compositions comprising an anti-Pro108 antibody and a carrier. These compositions can be provided in an article of manufacture or a kit. Another aspect of the invention is an isolated nucleic acid encoding an anti-Pro108 antibody, as well as an expression vector comprising the isolated nucleic acid. Also provided are cells that produce the anti-Pro108 antibodies. The invention encompasses a method of producing the anti-Pro108 antibodies. Other aspects of the invention are a method of killing an Pro108-expressing cancer cell, comprising contacting Pro108 present in the ECM with an anti-Pro108 antibody and a method of alleviating or treating an Pro108-expressing cancer in a mammal, comprising administering a therapeutically effective amount of the anti-Pro108 antibody to the mammal.09-17-2009
20110306057Phosphorylated RalA - Antibodies that are specific for human RalA that is phosphorylated at one or both of Ser183 and Ser194 are described as various methods such antibodies, including diagnostic methods and screening methods.12-15-2011

Patent applications by Laura Corral, San Francisco, CA US

Laura Corral, Jamaica Plain, MA US

Patent application numberDescriptionPublished
20090136490OVR110 ANTIBODY COMPOSITIONS AND METHODS FOR USE - The invention provides isolated anti-ovarian, pancreatic, lung or breast cancer antigen (Ovr110) antibodies that internalize upon binding to Ovr110 on a mammalian in vivo. The invention also encompasses compositions comprising an anti-Ovr110 antibody and a carrier. These compositions can be provided in an article of manufacture or a kit. Another aspect of the invention is an isolated nucleic acid encoding an anti-Ovr110 antibody, as well as an expression vector comprising the isolated nucleic acid. Also provided are cells that produce the anti-Ovr110 antibodies. The invention encompasses a method of producing the anti-Ovr110 antibodies. Other aspects of the invention are a method of killing an Ovr110-expressing cancer cell, comprising contacting the cancer cell with an anti-Ovr110 antibody and a method of alleviating or treating an Ovr110 expressing cancer in a mammal, comprising administering a therapeutically effective amount of the anti-Ovr110 antibody to the mammal.05-28-2009
20100209438OVR110 Antibody Compositions and Methods of Use - The invention provides isolated anti-ovarian, pancreatic, lung or breast cancer antigen (Ovr110) antibodies that internalize upon binding to Ovr110 on a mammalian in vivo. The invention also encompasses compositions comprising an anti-Ovr110 antibody and a carrier. These compositions can be provided in an article of manufacture or a kit. Another aspect of the invention is an isolated nucleic acid encoding an anti-Ovr110 antibody, as well as an expression vector comprising the isolated nucleic acid. Also provided are cells that produce the anti-Ovr110 antibodies. The invention encompasses a method of producing the anti-Ovr110 antibodies. Other aspects of the invention are a method of killing an Ovr110-expressing cancer cell, comprising contacting the cancer cell with an anti-Ovr110 antibody and a method of alleviating or treating an Ovr110-expressing cancer in a mammal, comprising administering a therapeutically effective amount of the anti-Ovr110 antibody to the mammal.08-19-2010

Laura G. Corral, San Diego, CA US

Patent application numberDescriptionPublished
20090232796METHOD OF TREATING CANCER BY ADMINISTERING AN IMMUNOMODULATORY COMPOUND IN COMBINATION WITH A CD40 ANTIBODY OR CD40 LIGAND - Provided herein relates to the field of cancer and its treatment by administering immunomodulatory compounds in combination with other compounds. In particular, a combination of an immunomodulatory compound and an anti-CD40 antibody and/or a CD40 ligand is provided.09-17-2009